ArticleTherapeutic advances in urology

Testosterone suppression and recovery in patients with advanced prostate cancer treated with intermittent androgen deprivation therapy with relugolix.

Patrick Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.